U.S. market Closed. Opens in 2 days 4 hours 7 minutes

BLAC | Bellevue Life Sciences Acquisition Corp. Stock Overview

(Stock Exchange: NASDAQ)
*Chart delayed
Analyzing fundamentals for BLAC we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is very weak. For more detailed analysis please see BLAC Fundamentals page.

More technicals details can be found on BLAC Technicals page.
An error has occurred. This application may no longer respond until reloaded. Reload 🗙